On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
On the first day of spring, March 19, 2024, the NCPR newsroom started a year-long series reporting on climate change in the North Country. Our goal was to look at how climate change is impacting every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback